| Product Code: ETC9568938 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden mRNA Flu Vaccine Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden mRNA Flu Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden mRNA Flu Vaccine Market - Industry Life Cycle |
3.4 Sweden mRNA Flu Vaccine Market - Porter's Five Forces |
3.5 Sweden mRNA Flu Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden mRNA Flu Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Sweden mRNA Flu Vaccine Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Sweden mRNA Flu Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of mRNA flu vaccines |
4.2.2 Growing demand for more effective and efficient flu vaccines |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 High production costs associated with mRNA flu vaccines |
4.3.2 Regulatory hurdles and approval processes for new vaccines |
4.3.3 Limited accessibility and affordability for certain population segments |
5 Sweden mRNA Flu Vaccine Market Trends |
6 Sweden mRNA Flu Vaccine Market, By Types |
6.1 Sweden mRNA Flu Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden mRNA Flu Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden mRNA Flu Vaccine Market Revenues & Volume, By Non-replicating mRNA, 2021- 2031F |
6.1.4 Sweden mRNA Flu Vaccine Market Revenues & Volume, By In Vivo Self-Replicating mRNA, 2021- 2031F |
6.1.5 Sweden mRNA Flu Vaccine Market Revenues & Volume, By In Vitro Dendritic Cell Non-Replicating mRNA Vaccine, 2021- 2031F |
6.2 Sweden mRNA Flu Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1010, 2021- 2031F |
6.2.3 Sweden mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1020, 2021- 2031F |
6.2.4 Sweden mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1030, 2021- 2031F |
6.3 Sweden mRNA Flu Vaccine Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Sweden mRNA Flu Vaccine Market Revenues & Volume, By Clinic, 2021- 2031F |
6.3.3 Sweden mRNA Flu Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Sweden mRNA Flu Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden mRNA Flu Vaccine Market Import-Export Trade Statistics |
7.1 Sweden mRNA Flu Vaccine Market Export to Major Countries |
7.2 Sweden mRNA Flu Vaccine Market Imports from Major Countries |
8 Sweden mRNA Flu Vaccine Market Key Performance Indicators |
8.1 Vaccine acceptance rate among the target population |
8.2 Rate of adoption of mRNA flu vaccines compared to traditional flu vaccines |
8.3 Number of vaccination campaigns supported by government initiatives |
9 Sweden mRNA Flu Vaccine Market - Opportunity Assessment |
9.1 Sweden mRNA Flu Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden mRNA Flu Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Sweden mRNA Flu Vaccine Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Sweden mRNA Flu Vaccine Market - Competitive Landscape |
10.1 Sweden mRNA Flu Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Sweden mRNA Flu Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here